Leeds Covid-19 stats as Yorkshire hospitals record deadliest day for Covid-19 in seven weeks
Leeds coronavirus infection rate shot up in the fist week of January
The video will auto-play soon8Cancel
Play now
free email newsletterInvalid EmailSomething went wrong, please try again later.
Subscribe
When you subscribe we will use the information you provide to send you these newsletters. Your information will be used in accordance with ourPrivacy Notice.
Thank you for subscribingWe have more newslettersShow meSee ourprivacy notice
Leeds confirmed more new cases of coronavirus than anywhere else in Yorkshire over the past 24 hours.
Over the same period, the district s hospitals recorded 12 new Covid patient deaths - the third-highest toll of any NHS Trust in Yorkshire.
A drug used to treat osteoporosis could halve the number of hip replacement re-operations. Scientists have discovered the drug denosumab could help protect the hip bone.
Credit: University of Sheffield
Osteolysis - a disease that eats away at bone tissue - is the leading reason for joint replacement reoperation
An estimated 8,500 hip revision procedures are conducted in England, Wales and Northern Ireland each year at a large cost to the NHS, with repeat procedures less likely to be as effective as first time surgery due to weakened bone
Researchers from the University of Sheffield and Sheffield Teaching Hospitals found the osteoporosis drug, denosumab, could protect patients from osteolysis, reduce the need for re-operations, and reduce the health burden of this disease
More than half of repeat hip replacement operations could be prevented with a drug already successfully used to treat osteoporosis, new research from the University of Sheffield and Sheffield Teaching Hospitals NHS Foundation Trust has revealed.
A drug used to treat osteoporosis could halve the number of hip replacement re-operations. Scientists have discovered the drug denosumab could help protect the hip bone.